GAL-101
N/A
Report date: 2024/12/27 10:50:18
NME
Base Information
Drug NameGAL-101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTel Aviv University Trust
China Registration ClassN/A
Develop Information
Active CompaniesGalimedix Therapeutics IncThéa Open Innovation
Inactive CompaniesMerz Pharmaceuticals Gmbh
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A